Updated national and international hypertension guidelines: a review of current recommendations - Test2 - elhamkhani - TriplyDB

Updated national and international hypertension guidelines: a review of current recommendations

Updated national and international hypertension guidelines: a review of current recommendations

http://www.wikidata.org/entity/Q26824589

about

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial Angiotensinogen (AGT) M235T, AGT T174M and Angiotensin-1-Converting Enzyme (ACE) I/D Gene Polymorphisms in Essential Hypertension: Effects on Ramipril Efficacy.Association of Sleep Disordered Breathing with Wake-Up Acute Ischemic Stroke: A Full Polysomnographic Study.High Prevalence of Hypertension in a Danish Population Telemedical Home Measurement of Blood Pressure in Citizens Aged 55-64 Years in Holstebro County.Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene.Hypertension Attitude PersPEctives and Needs (HAPPEN): A Real-World Survey of Physicians and Patients With Hypertension in China.Hypertension in Older Persons: A Systematic Review of National and International Treatment Guidelines.Benefits and risks of antihypertensive medications in the elderly.Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease.Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe.Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions.Vasorelaxant effects of Angelica decursiva root on isolated rat aortic rings Combination of β Adrenergic Receptor Block and Renin-Angiotensin System Inhibition Diminished the Angiotensin II-Induced Vasoconstriction and Increased Bradykinin-Induced Vasodilation in Hypertension.Antihypertensive medication adherence and blood pressure control among central Alabama veterans.Where are we going? Translational research in hepatic encephalopathy.Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study.Metabolic Syndrome and cognitive decline in the elderly: A systematic review.Machine learning of big data in gaining insight into successful treatment of hypertension.Inflammation and oxidative stress markers in diabetes and hypertension.

P2860

Q28049690-5D219F7B-BE98-481F-A9B7-FADF004277C8 Q33607150-D28DC275-FDB1-4E95-B36F-A552AC4F474A Q35959952-5969917B-A97B-45E5-894D-9173D94CDC23 Q36305422-B81F6F7F-69FB-4AF7-BD4F-9B036AA7EE53 Q36622923-93338F02-3843-43FD-96C6-F69C1F695409 Q36696052-8DED4DAA-4055-453B-A6E0-61C630073623 Q36950124-2ED8065E-A379-43D8-ACD2-FE80F07916E8 Q37685756-90A3BF1B-62F7-4B43-B755-11736AEABFB6 Q37696511-63717613-3146-4CC5-86FB-E6207CDB0F0B Q38397552-57A31CA5-B816-4CF4-81E6-0F14CBAC41C6 Q38615589-F01CC590-3A56-4B55-AF60-41B462BE7D1A Q38658657-A3AACE6F-EF68-43CC-BA09-E59E644C1354 Q39229631-6A34AC91-1610-4CC6-B67A-B4AB6E7943D4 Q39717221-606F6DEE-05D0-4F88-BD17-1D0DE01F85EC Q42008187-41C1B3BC-861E-4558-990E-EC06D5002371 Q44636397-94E2A70D-D9D8-462E-A2D7-3C9723832FF2 Q45327050-AD5A7A32-F6CA-4D51-AC25-F3B558154C67 Q52149705-461C0E68-5293-49EA-A654-FDEB83DDE78E Q52846002-761ECAFB-8AFD-42E0-A1B3-28F6A4339196 Q54961329-29A9DEE0-480F-4988-9EFC-275D635BD0F0 Q55086775-73B02CEF-AEDE-4568-A36A-61F48FABDA50 Q55397021-EF084586-CB48-4509-B161-6F1881772F07

P2860

Updated national and international hypertension guidelines: a review of current recommendations

http://www.wikidata.org/entity/Q26824589

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Updated national and internati ...... iew of current recommendations

@ast

Updated national and internati ...... iew of current recommendations

@en

Updated national and internati ...... iew of current recommendations

@nl

type

label

Updated national and internati ...... iew of current recommendations

@ast

Updated national and internati ...... iew of current recommendations

@en

Updated national and internati ...... iew of current recommendations

@nl

prefLabel

Updated national and internati ...... iew of current recommendations

@ast

Updated national and internati ...... iew of current recommendations

@en

Updated national and internati ...... iew of current recommendations

@nl

P1433

Q26824589-7FD16298-A63F-41A8-98E0-B2E95F280A6B

P1476

Q26824589-A8FDF76A-A0D9-451B-938A-CC560A1093D0

P2093

Q26824589-104AF0BB-3505-4B76-8637-D08BFB32AC7E

Q26824589-1D884119-7EFC-4AFC-9E32-994DD68ACF96

Q26824589-5E18DE09-35AB-4228-B6DE-06D36CD2C346

Q26824589-69309717-BF0E-4250-BA41-00EE195D0B68

Q26824589-863E6D3A-40F4-4A67-9107-7C44CBE88177

Q26824589-893C3A8F-0F5F-4AA2-BD51-60400B3C9A8B

Q26824589-8C8C149F-0BCA-4B81-AF90-5BA2E47FCCB1

Q26824589-95566E03-56B4-4343-ABDF-B9978F12C73A

P2860

Q26824589-01BBA889-0F7D-4D9A-B64C-D86E9A5CE1AD

Q26824589-088223CD-1581-48AA-BD7B-710F86A4DC2E

Q26824589-0E44DBC8-1383-4F25-9809-36E04558A586

Q26824589-13D72BA1-18C8-4A0E-A1E2-67C7BB0A991D

Q26824589-14EB7ECF-1D85-4D29-93A7-F30CCDED4331

Q26824589-16048168-9F68-46B9-9B8D-86EDE6E5DB57

Q26824589-1829169A-EDA9-49E6-968C-7D6BCAF9B158

Q26824589-1D2AC40C-D8F9-4FDE-9F89-1417202985D6

Q26824589-260E7AC7-5E3E-41CC-92D8-6E907B0FE4B7

Q26824589-3A1691A4-C72F-4B89-8868-FD50473726B9

P2888

Q26824589-05678CAE-4C1C-4945-966E-00D143687EE9

P304

Q26824589-7D1CB065-C264-4AC0-B43A-9CF159FDE507

P31

Q26824589-8E258BAD-42DD-4732-9940-33884E67BB20

Q26824589-C85DFEBB-9E6A-4176-A4E3-B83522DFDCD7

P356

Q26824589-89C7323F-0CDC-4E78-A1B2-89539B0C50DB

P407

Q26824589-110BE100-837B-46FC-9314-D55DD29C3651

P433

Q26824589-D553CA25-77FE-4035-9902-C37DDA328061

P478

Q26824589-08EB5181-95DE-48EB-80E4-75A83DD42586

P50

Q26824589-C50B2F3D-3021-42C5-A351-38AB4CAB339A

P577

Q26824589-3C66A7D5-377A-4BB5-8C5E-394D35387AFD

Q26824589-FE000B16-B6E6-49AF-9CF1-281FA1B5A413

P5875

Q26824589-BA775A11-9ADD-4976-9F5A-712FB5E5EE59

P6179

Q26824589-ECE31B17-E395-4D4F-A700-842BEE113586

P698

Q26824589-29763806-AA8F-487C-BA60-FBBE3891356A

P921

Q26824589-3E5C4682-0B2D-4B9D-B0C6-715DAADC8544

P932

Q26824589-B0E63929-BE0D-4247-BF0E-BA8771DBA674

P356

S40265-014-0306-5

P1433

P1476

Updated national and internati ...... iew of current recommendations

@en

P2093

Bryan Williams

http://www.w3.org/2001/XMLSchema#string

Chern-En Chiang

http://www.w3.org/2001/XMLSchema#string

Jean-Jacques Mourad

http://www.w3.org/2001/XMLSchema#string

Liu Lisheng

http://www.w3.org/2001/XMLSchema#string

Ross D. Feldman

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Weizhong Zhang

http://www.w3.org/2001/XMLSchema#string

Zhaosu Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence Supporting a Systolic Blood Pressure Goal of Less Than 150 mm Hg in Patients Aged 60 Years or Older: The Minority View

An Effective Approach to High Blood Pressure Control: A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Beta-blockers for hypertension

Treatment blood pressure targets for hypertension

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

P2888

s40265-014-0306-5

P304

2033-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-014-0306-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

Sverre E. Kjeldsen

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266945331

http://www.w3.org/2001/XMLSchema#string

P6179

1007758555

http://www.w3.org/2001/XMLSchema#string

P698

25315030

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

4224739

http://www.w3.org/2001/XMLSchema#string